Submitted on Thursday 14th January 2016
Published on Thursday 21st January 2016
Current status: Closed
Closed: Thursday 21st July 2016
Signatures: 136
Reinstate the use of bevacizumab (Avastin) for use on all Cancers.
Fewer signatures
More signatures
Colours relate to the distribution of signatures across different constituencies and not to the absolute number.
Constituency boundaries are slightly simplified in order to minimise loading time. More detailed boundaries are shown on individual constituency pages.
3.144.193.129 Wed, 08 May 2024 18:55:58 +0100
